GCG and hypertensive disorder: Examining the use of GLP-1 agonists in pediatric patients with hypertension, dyslipidemia, hypertriglyceridemia, and abdominal obesity may provide insights into the potential of these drugs to mitigate cardiovascular illnesses in obese adolescents.